Future research priorities for morbidity control of lymphedema

• Glavni autori: S R Narahari (Autor), Madhur Guruprasad Aggithaya (Autor), Christine Moffatt (Autor), T J Ryan (Autor), Vaughan Keeley (Autor), B Vijaya (Autor), P Rajendran (Autor), S B Karalam (Autor), S Rajagopala (Autor), N K Kumar (Autor), K S Bose (Autor), K V Sushma (Autor)
• Format: Knjiga
• Izdano: Wolters Kluwer Medknow Publications, 2017-01-01T00:00:00Z.
• Teme: article
• Online pristup: Connect to this object online.

Background: Innovation in the treatment of lower extremity lymphedema has received low priority from the governments and pharmaceutical industry. Advancing lymphedema is irreversible and initiates fibrosis in the dermis, reactive changes in the epidermis and subcutis. Most medical treatments offered...